V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330013266 | 330005982 | null | null | Curative (C) | 2019-04-17 | 2020-02-14 | Cyclophosphamide High Dose | null | null | 330025052 | AML19 TRIAL |
| 330013267 | 330006023 | 0 | 58 | Curative (C) | 2016-04-20 | 2016-05-11 | VIDE | 2 | N | 330006361 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 330013268 | 330009352 | 1.67 | null | Palliative (P) | 2017-05-25 | 2017-09-28 | R GCVP | N | N | 330007206 | IPILIMUMAB |
| 330013269 | 330002938 | 0 | 12.5 | Palliative (P) | 2015-02-03 | 2015-02-07 | LCH guideline Gp1 Continuation treatment | null | null | 330000050 | NOT MATCHED |
| 330013270 | 330003048 | 1.59 | 71.6 | Curative (C) | null | 2013-10-08 | Cisplatin + Radiotherapy | null | null | 330000516 | CISPLATIN + RT |
| 330013271 | 330003633 | null | 77 | Disease modification (D) | 2018-06-26 | 2018-07-06 | NB Low/Intermed risk guidelines CADO | 01 | N | 330005520 | NOT MATCHED |
| 330013272 | 330007964 | null | 55.3 | Palliative (P) | 2018-12-01 | 2018-12-01 | Trial Unspecified | 1 | N | 330005616 | TRIAL |
| 330013273 | 330003664 | 1.82 | 81 | Palliative (P) | 2018-12-14 | 2018-12-25 | EW EuroEwing 2012 Arm B IE | null | null | 330005682 | TRIAL |
| 330013274 | 330012360 | 1.76 | 85.6 | Palliative (P) | null | 2014-11-23 | DOXORUBICIN | 02 | null | 330006926 | DOXORUBICIN |
| 330013275 | 330003870 | 1.66 | 61.9 | Palliative (P) | 2018-03-19 | 2018-03-19 | EW EuroEwing 2012 Arm B VDC | N | null | 330007616 | TRIAL |
| 330013276 | 330003899 | 1.81 | 77.8 | Adjuvant (A) | null | 2017-08-25 | MIFAMURTIDE | N | null | 330007724 | MIFAMURTIDE |
| 330013277 | 330008141 | 0 | 58.5 | Curative (C) | 2014-10-26 | 2015-01-23 | Cisplatin | 02 | N | 330007971 | CISPLATIN |
| 330013278 | 330003986 | 1.58 | 53.9 | Palliative (P) | 2014-08-22 | 2014-08-30 | ETOPOSIDE + IFOSFAMIDE | null | null | 330008138 | ETOPOSIDE + IFOSFAMIDE |
| 330013279 | 330004002 | 1.61 | 0 | Curative (C) | 2016-06-23 | 2016-06-25 | Etoposide + Ifosfamide (5 days) | 02 | N | 330008194 | ETOPOSIDE + IFOSFAMIDE |
| 330013280 | 330004132 | 1.64 | 52.9 | Palliative (P) | 2016-05-23 | 2016-10-04 | Etoposide + Ifosfamide (5 days) | N | N | 330009031 | ETOPOSIDE + IFOSFAMIDE |
| 330013282 | 330004161 | 1.79 | null | Palliative (P) | 2018-03-19 | 2018-03-19 | Etoposide + Ifosfamide (5 days) | Y | null | 330009184 | ETOPOSIDE + IFOSFAMIDE |
| 330013284 | 330010500 | 1.69 | 87.6 | Curative (C) | 2019-06-24 | 2019-09-15 | Carboplatin AUC 2 - 5 | 02 | N | 330009744 | CARBOPLATIN |
| 330013285 | 330004213 | null | null | Palliative (P) | 2018-10-09 | 2018-10-09 | Cetuximab + Radiotherapy Maint | 02 | Y | 330009753 | CETUXIMAB + RT |
| 330013286 | 330004304 | 1.6 | 81.3 | Palliative (P) | 2015-08-02 | 2015-08-05 | Paclitaxel 7 day | N | N | 330011097 | PACLITAXEL |
| 330013288 | 330004784 | 1.7 | 61.1 | Palliative (P) | 2020-01-10 | 2020-01-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330013538 | CARBOPLATIN + PACLITAXEL |
| 330013290 | 330005126 | 1.75 | 24.4 | null | null | 2018-09-29 | Methotrexate intrathecal | N | N | 330017013 | METHOTREXATE INTRATHECAL |
| 330013292 | 330005213 | 1.81 | null | Not known (9) | 2019-08-16 | 2019-08-21 | FLAG + Idarubicin | 02 | N | 330017874 | FLAG + IDARUBICIN |
| 330013293 | 330005380 | 0 | 97.2 | Curative (C) | 2014-07-26 | 2015-03-12 | Vinblastine | 2 | N | 330019906 | VINBLASTINE |
| 330013295 | 330009044 | 1.54 | 58 | null | 2015-11-29 | 2016-03-20 | PAC-PLAT | N | N | 330021428 | DOXORUBICIN + IFOSFAMIDE |
| 330013296 | 330005599 | 1.73 | 22.2 | Palliative (P) | 2017-02-23 | 2017-02-24 | Carboplatin + Docetaxel | N | N | 330021653 | IVE |
| 330013298 | 330005728 | 1.64 | 57 | Palliative (P) | 2019-10-30 | 2019-10-31 | Capecitabine + Streptozocin | 01 | N | 330023279 | IPILIMUMAB |
| 330013299 | 330009134 | 1.58 | 59 | Curative (C) | 2020-03-10 | 2020-03-11 | CLADRIBINE | N | N | 330023355 | RMS 2005 TRIAL |
| 330013301 | 330005912 | 1.65 | 126 | null | 2016-04-18 | 2016-04-23 | Cyclophosphamide oral | N | null | 330024541 | CVP R |
| 330013302 | 330006024 | null | 67 | Curative (C) | 2015-11-24 | 2016-06-14 | FCR | null | null | 330006361 | BEP |
| 330013303 | 330011098 | null | null | Palliative (P) | 2017-08-05 | 2017-12-07 | PEMBROLIZUMAB | N | N | 330007206 | VIDE |
| 330013304 | 330012307 | 0 | 22.5 | Palliative (P) | 2015-03-21 | 2015-03-21 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | 330000050 | NOT MATCHED |
| 330013305 | 330003049 | null | 57.9 | Palliative (P) | 2014-03-22 | 2014-03-27 | CNS GCT II Non Germin - HDose PEI | 2 | N | 330000516 | NOT MATCHED |
| 330013306 | 330003633 | null | 60.9 | Palliative (P) | null | 2018-12-11 | CNS LGG 2004 03 cons vinc +cyclo | N | N | 330005520 | NOT MATCHED |
| 330013307 | 330003651 | 1.71 | 53.3 | Palliative (P) | 2015-03-25 | 2018-12-22 | METHOTREXATE | 01 | N | 330005616 | METHOTREXATE |
| 330013308 | 330003665 | 1.64 | 72.4 | Curative (C) | 2018-11-27 | 2018-12-25 | Cisplatin | null | null | 330005682 | CISPLATIN |
| 330013309 | 330003900 | 1.04 | 42.4 | Palliative (P) | 2017-09-19 | 2017-09-29 | Trial Unspecified | N | null | 330007724 | TRIAL |
| 330013310 | 330008141 | 1.9 | 54.9 | Adjuvant (A) | null | 2015-11-06 | METHOTREXATE | Y | null | 330007971 | METHOTREXATE |
| 330013311 | 330004002 | 1.77 | 66.4 | Curative (C) | 2016-08-06 | 2016-08-31 | Rituximab | 02 | N | 330008194 | RITUXIMAB |
| 330013312 | 330004132 | 1.67 | 97.5 | Palliative (P) | 2016-08-13 | 2016-10-26 | Etoposide + Ifosfamide (3 days) | N | N | 330009031 | ETOPOSIDE + IFOSFAMIDE |
| 330013313 | 330004161 | null | 58.7 | Palliative (P) | 2018-03-19 | 2018-03-19 | CETUXIMAB | 99 | null | 330009184 | CETUXIMAB |
| 330013314 | 330004213 | 0 | 69.2 | Palliative (P) | 2018-03-12 | 2018-10-10 | Cetuximab + Radiotherapy Load | 02 | N | 330009753 | CETUXIMAB + RT |
| 330013315 | 330008353 | 1.72 | 90.9 | Disease modification (D) | 2016-07-16 | 2016-08-09 | NIVOLUMAB | 02 | null | 330011097 | TEMOZOLOMIDE |
| 330013318 | 330008843 | 1.63 | null | Palliative (P) | null | 2019-10-24 | FCarboSt | N | Y | 330017874 | IFOSFAMIDE |
| 330013319 | 330005600 | null | 35.75 | Curative (C) | 2017-02-24 | 2017-02-24 | CISPLATIN + EPIRUBICIN | N | null | 330021653 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330013320 | 330005746 | 1.65 | 42.2 | null | 2020-03-05 | 2020-03-11 | Ifosfamide | 02 | N | 330023355 | CYTARABINE |
| 330013322 | 330002939 | 1.76 | 65 | Curative (C) | 2015-04-08 | 2015-04-08 | Cisplatin + Radiotherapy | null | null | 330000050 | CISPLATIN + RT |
| 330013323 | 330007623 | 0 | null | Palliative (P) | 2014-06-05 | 2014-07-10 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330000516 | NOT MATCHED |
| 330013324 | 330003634 | null | 93.7 | Curative (C) | 2018-06-16 | 2018-12-11 | NB HRNBL-1 Isotretinoin | N | N | 330005520 | NOT MATCHED |
| 330013325 | 330003651 | 1.51 | 44.7 | Adjuvant (A) | 2018-12-15 | 2018-12-22 | Cisplatin + Radiotherapy | N | N | 330005616 | CISPLATIN + RT |
| 330013326 | 330003666 | null | 47.7 | Palliative (P) | 2019-01-01 | 2019-01-01 | Doxorubicin 75mg/m2 | N | N | 330005682 | DOXORUBICIN |